{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 27,
   "id": "2e690696",
   "metadata": {},
   "outputs": [],
   "source": [
    "#Importação\n",
    "import pandas as pd"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "id": "0aa12809",
   "metadata": {},
   "outputs": [],
   "source": [
    "#Definiçao dos arquivos que serão utilizados\n",
    "df_Variant = pd.read_csv('01-Apr-2022-VariantSummaries.csv')\n",
    "df_Evidences = pd.read_csv('01-Apr-2022-ClinicalEvidenceSummaries.csv')\n",
    "df_Gene = pd.read_csv('01-Apr-2022-GeneSummaries.csv')\n",
    "df_Assertion = pd.read_csv('01-Apr-2022-AssertionSummaries.csv')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "id": "ae7df362",
   "metadata": {},
   "outputs": [],
   "source": [
    "#Para que o merge funcione iremos trocar o nome da coluna name para gene.\n",
    "df_Assertion.rename(columns={'assertion_type': 'evidence_type'}, inplace = True)\n",
    "df_Assertion.rename(columns={'assertion_direction': 'evidence_direction'}, inplace = True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "id": "e47a68a2",
   "metadata": {},
   "outputs": [],
   "source": [
    "df_Assertion = df_Assertion.drop(['acmg_codes', 'amp_category', 'nccn_guideline', \n",
    "                                  'fda_companion_test', 'assertion_summary', 'assertion_description',\n",
    "                                  'assertion_id', 'fda_companion_test', 'regulatory_approval',\n",
    "                                  'assertion_civic_url', 'evidence_item_ids', 'nccn_guideline_version', 'evidence_items_civic_url' ],axis=1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "id": "a136aea7",
   "metadata": {},
   "outputs": [],
   "source": [
    "Civic = pd.merge(df_Assertion, df_Evidences, how='outer')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "id": "81f80d8e",
   "metadata": {},
   "outputs": [],
   "source": [
    "Civic = pd.merge(Civic, df_Variant,  left_on='variant_id', right_on='variant_id', how='left', suffixes=('','_y'))\n",
    "Civic.drop(Civic.filter(regex='_y$').columns, axis=1, inplace=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "id": "03e51edc",
   "metadata": {},
   "outputs": [],
   "source": [
    "df_Gene = df_Gene.drop(['gene_civic_url', 'gene_id', 'last_review_date', 'is_flagged'],axis=1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "id": "ba18ab8a",
   "metadata": {},
   "outputs": [],
   "source": [
    "#Para que o merge funcione iremos trocar o nome da coluna name para gene.\n",
    "df_Gene.rename(columns={'name': 'gene'}, inplace = True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "id": "c468f492",
   "metadata": {},
   "outputs": [],
   "source": [
    "Civic = pd.merge(Civic, df_Gene,  left_on='gene', right_on='gene', how='left', suffixes=('','_y'))\n",
    "Civic.drop(Civic.filter(regex='_y$').columns, axis=1, inplace=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "id": "6e4e915f",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>gene</th>\n",
       "      <th>entrez_id</th>\n",
       "      <th>variant</th>\n",
       "      <th>disease</th>\n",
       "      <th>doid</th>\n",
       "      <th>phenotypes</th>\n",
       "      <th>drugs</th>\n",
       "      <th>evidence_type</th>\n",
       "      <th>evidence_direction</th>\n",
       "      <th>clinical_significance</th>\n",
       "      <th>...</th>\n",
       "      <th>variant_origin</th>\n",
       "      <th>summary</th>\n",
       "      <th>variant_types</th>\n",
       "      <th>hgvs_expressions</th>\n",
       "      <th>civic_variant_evidence_score</th>\n",
       "      <th>allele_registry_id</th>\n",
       "      <th>clinvar_ids</th>\n",
       "      <th>variant_aliases</th>\n",
       "      <th>assertion_ids</th>\n",
       "      <th>description</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>ERBB2</td>\n",
       "      <td>2064</td>\n",
       "      <td>Amplification</td>\n",
       "      <td>Her2-receptor Positive Breast Cancer</td>\n",
       "      <td>60079.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Trastuzumab</td>\n",
       "      <td>Predictive</td>\n",
       "      <td>Supports</td>\n",
       "      <td>Sensitivity/Response</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>CCND1 amplification has been implicated in poo...</td>\n",
       "      <td>transcript_amplification</td>\n",
       "      <td>NaN</td>\n",
       "      <td>47.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1,2</td>\n",
       "      <td>ERBB2, commonly referred to as HER2, is amplif...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>ALK</td>\n",
       "      <td>238</td>\n",
       "      <td>Fusion</td>\n",
       "      <td>Lung Non-small Cell Carcinoma</td>\n",
       "      <td>3908.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Crizotinib</td>\n",
       "      <td>Predictive</td>\n",
       "      <td>Supports</td>\n",
       "      <td>Sensitivity/Response</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Following the initial discovery and characteri...</td>\n",
       "      <td>transcript_fusion</td>\n",
       "      <td>NaN</td>\n",
       "      <td>648.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>REARRANGEMENT</td>\n",
       "      <td>3,34</td>\n",
       "      <td>ALK amplifications, fusions and mutations have...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>VHL</td>\n",
       "      <td>7428</td>\n",
       "      <td>R167Q (c.500G&gt;A)</td>\n",
       "      <td>Von Hippel-Lindau Disease</td>\n",
       "      <td>14175.0</td>\n",
       "      <td>Retinal capillary hemangioma,Pheochromocytoma,...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Predisposing</td>\n",
       "      <td>Supports</td>\n",
       "      <td>Pathogenic</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>R167Q is the most common point mutation in her...</td>\n",
       "      <td>missense_variant</td>\n",
       "      <td>NM_000551.3:c.500G&gt;A,NP_000542.1:p.Arg167Gln,N...</td>\n",
       "      <td>95.0</td>\n",
       "      <td>CA020454</td>\n",
       "      <td>2216</td>\n",
       "      <td>C.500G&gt;A,ARG167GLN,RS5030821</td>\n",
       "      <td>4</td>\n",
       "      <td>Von Hippel-Lindau (VHL) disease is characteriz...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>EGFR</td>\n",
       "      <td>1956</td>\n",
       "      <td>L858R</td>\n",
       "      <td>Lung Non-small Cell Carcinoma</td>\n",
       "      <td>3908.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Gefitinib,Erlotinib</td>\n",
       "      <td>Predictive</td>\n",
       "      <td>Supports</td>\n",
       "      <td>Sensitivity/Response</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>EGFR L858R has long been recognized as a funct...</td>\n",
       "      <td>missense_variant</td>\n",
       "      <td>NC_000007.13:g.55259515T&gt;G,NM_005228.4:c.2573T...</td>\n",
       "      <td>375.0</td>\n",
       "      <td>CA126713</td>\n",
       "      <td>376280,376282,16609</td>\n",
       "      <td>LEU858ARG,RS121434568</td>\n",
       "      <td>5,6</td>\n",
       "      <td>EGFR is widely recognized for its importance i...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>EGFR</td>\n",
       "      <td>1956</td>\n",
       "      <td>L858R</td>\n",
       "      <td>Lung Non-small Cell Carcinoma</td>\n",
       "      <td>3908.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Afatinib</td>\n",
       "      <td>Predictive</td>\n",
       "      <td>Supports</td>\n",
       "      <td>Sensitivity/Response</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>EGFR L858R has long been recognized as a funct...</td>\n",
       "      <td>missense_variant</td>\n",
       "      <td>NC_000007.13:g.55259515T&gt;G,NM_005228.4:c.2573T...</td>\n",
       "      <td>375.0</td>\n",
       "      <td>CA126713</td>\n",
       "      <td>376280,376282,16609</td>\n",
       "      <td>LEU858ARG,RS121434568</td>\n",
       "      <td>5,6</td>\n",
       "      <td>EGFR is widely recognized for its importance i...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3914</th>\n",
       "      <td>ERCC1</td>\n",
       "      <td>2067</td>\n",
       "      <td>Underexpression</td>\n",
       "      <td>Ovary Epithelial Cancer</td>\n",
       "      <td>2152.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Platinum Compound</td>\n",
       "      <td>Predictive</td>\n",
       "      <td>Supports</td>\n",
       "      <td>Sensitivity/Response</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>15.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3915</th>\n",
       "      <td>NTRK1</td>\n",
       "      <td>4914</td>\n",
       "      <td>Amplification</td>\n",
       "      <td>Solid Tumor</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Larotrectinib</td>\n",
       "      <td>Predictive</td>\n",
       "      <td>Supports</td>\n",
       "      <td>Sensitivity/Response</td>\n",
       "      <td>...</td>\n",
       "      <td>Somatic</td>\n",
       "      <td>NaN</td>\n",
       "      <td>transcript_amplification</td>\n",
       "      <td>NaN</td>\n",
       "      <td>5.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3916</th>\n",
       "      <td>CTCF</td>\n",
       "      <td>10664</td>\n",
       "      <td>K365T</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Functional</td>\n",
       "      <td>Supports</td>\n",
       "      <td>Gain of Function</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3917</th>\n",
       "      <td>KIT</td>\n",
       "      <td>3815</td>\n",
       "      <td>EXPRESSION</td>\n",
       "      <td>Glioblastoma</td>\n",
       "      <td>3068.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Sunitinib</td>\n",
       "      <td>Predictive</td>\n",
       "      <td>Supports</td>\n",
       "      <td>Sensitivity/Response</td>\n",
       "      <td>...</td>\n",
       "      <td>Somatic</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>20.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>c-KIT activation has been shown to have oncoge...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3918</th>\n",
       "      <td>SSTR5</td>\n",
       "      <td>6755</td>\n",
       "      <td>expression</td>\n",
       "      <td>Neuroendocrine Tumor</td>\n",
       "      <td>169.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Pasireotide</td>\n",
       "      <td>Predictive</td>\n",
       "      <td>Supports</td>\n",
       "      <td>Sensitivity/Response</td>\n",
       "      <td>...</td>\n",
       "      <td>Somatic</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>3919 rows × 41 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "       gene  entrez_id           variant  \\\n",
       "0     ERBB2       2064     Amplification   \n",
       "1       ALK        238            Fusion   \n",
       "2       VHL       7428  R167Q (c.500G>A)   \n",
       "3      EGFR       1956             L858R   \n",
       "4      EGFR       1956             L858R   \n",
       "...     ...        ...               ...   \n",
       "3914  ERCC1       2067   Underexpression   \n",
       "3915  NTRK1       4914     Amplification   \n",
       "3916   CTCF      10664             K365T   \n",
       "3917    KIT       3815        EXPRESSION   \n",
       "3918  SSTR5       6755        expression   \n",
       "\n",
       "                                   disease     doid  \\\n",
       "0     Her2-receptor Positive Breast Cancer  60079.0   \n",
       "1            Lung Non-small Cell Carcinoma   3908.0   \n",
       "2                Von Hippel-Lindau Disease  14175.0   \n",
       "3            Lung Non-small Cell Carcinoma   3908.0   \n",
       "4            Lung Non-small Cell Carcinoma   3908.0   \n",
       "...                                    ...      ...   \n",
       "3914               Ovary Epithelial Cancer   2152.0   \n",
       "3915                           Solid Tumor      NaN   \n",
       "3916                                   NaN      NaN   \n",
       "3917                          Glioblastoma   3068.0   \n",
       "3918                  Neuroendocrine Tumor    169.0   \n",
       "\n",
       "                                             phenotypes                drugs  \\\n",
       "0                                                   NaN          Trastuzumab   \n",
       "1                                                   NaN           Crizotinib   \n",
       "2     Retinal capillary hemangioma,Pheochromocytoma,...                  NaN   \n",
       "3                                                   NaN  Gefitinib,Erlotinib   \n",
       "4                                                   NaN             Afatinib   \n",
       "...                                                 ...                  ...   \n",
       "3914                                                NaN    Platinum Compound   \n",
       "3915                                                NaN        Larotrectinib   \n",
       "3916                                                NaN                  NaN   \n",
       "3917                                                NaN            Sunitinib   \n",
       "3918                                                NaN          Pasireotide   \n",
       "\n",
       "     evidence_type evidence_direction clinical_significance  ...  \\\n",
       "0       Predictive           Supports  Sensitivity/Response  ...   \n",
       "1       Predictive           Supports  Sensitivity/Response  ...   \n",
       "2     Predisposing           Supports            Pathogenic  ...   \n",
       "3       Predictive           Supports  Sensitivity/Response  ...   \n",
       "4       Predictive           Supports  Sensitivity/Response  ...   \n",
       "...            ...                ...                   ...  ...   \n",
       "3914    Predictive           Supports  Sensitivity/Response  ...   \n",
       "3915    Predictive           Supports  Sensitivity/Response  ...   \n",
       "3916    Functional           Supports      Gain of Function  ...   \n",
       "3917    Predictive           Supports  Sensitivity/Response  ...   \n",
       "3918    Predictive           Supports  Sensitivity/Response  ...   \n",
       "\n",
       "      variant_origin                                            summary  \\\n",
       "0                NaN  CCND1 amplification has been implicated in poo...   \n",
       "1                NaN  Following the initial discovery and characteri...   \n",
       "2                NaN  R167Q is the most common point mutation in her...   \n",
       "3                NaN  EGFR L858R has long been recognized as a funct...   \n",
       "4                NaN  EGFR L858R has long been recognized as a funct...   \n",
       "...              ...                                                ...   \n",
       "3914             NaN                                                NaN   \n",
       "3915         Somatic                                                NaN   \n",
       "3916             NaN                                                NaN   \n",
       "3917         Somatic                                                NaN   \n",
       "3918         Somatic                                                NaN   \n",
       "\n",
       "                 variant_types  \\\n",
       "0     transcript_amplification   \n",
       "1            transcript_fusion   \n",
       "2             missense_variant   \n",
       "3             missense_variant   \n",
       "4             missense_variant   \n",
       "...                        ...   \n",
       "3914                       NaN   \n",
       "3915  transcript_amplification   \n",
       "3916                       NaN   \n",
       "3917                       NaN   \n",
       "3918                       NaN   \n",
       "\n",
       "                                       hgvs_expressions  \\\n",
       "0                                                   NaN   \n",
       "1                                                   NaN   \n",
       "2     NM_000551.3:c.500G>A,NP_000542.1:p.Arg167Gln,N...   \n",
       "3     NC_000007.13:g.55259515T>G,NM_005228.4:c.2573T...   \n",
       "4     NC_000007.13:g.55259515T>G,NM_005228.4:c.2573T...   \n",
       "...                                                 ...   \n",
       "3914                                                NaN   \n",
       "3915                                                NaN   \n",
       "3916                                                NaN   \n",
       "3917                                                NaN   \n",
       "3918                                                NaN   \n",
       "\n",
       "     civic_variant_evidence_score allele_registry_id          clinvar_ids  \\\n",
       "0                            47.0                NaN                  NaN   \n",
       "1                           648.0                NaN                  NaN   \n",
       "2                            95.0           CA020454                 2216   \n",
       "3                           375.0           CA126713  376280,376282,16609   \n",
       "4                           375.0           CA126713  376280,376282,16609   \n",
       "...                           ...                ...                  ...   \n",
       "3914                         15.0                NaN                  NaN   \n",
       "3915                          5.0                NaN                  NaN   \n",
       "3916                          0.0                NaN                  NaN   \n",
       "3917                         20.0                NaN                  NaN   \n",
       "3918                          0.0                NaN                  NaN   \n",
       "\n",
       "                   variant_aliases assertion_ids  \\\n",
       "0                              NaN           1,2   \n",
       "1                    REARRANGEMENT          3,34   \n",
       "2     C.500G>A,ARG167GLN,RS5030821             4   \n",
       "3            LEU858ARG,RS121434568           5,6   \n",
       "4            LEU858ARG,RS121434568           5,6   \n",
       "...                            ...           ...   \n",
       "3914                           NaN           NaN   \n",
       "3915                           NaN           NaN   \n",
       "3916                           NaN           NaN   \n",
       "3917                           NaN           NaN   \n",
       "3918                           NaN           NaN   \n",
       "\n",
       "                                            description  \n",
       "0     ERBB2, commonly referred to as HER2, is amplif...  \n",
       "1     ALK amplifications, fusions and mutations have...  \n",
       "2     Von Hippel-Lindau (VHL) disease is characteriz...  \n",
       "3     EGFR is widely recognized for its importance i...  \n",
       "4     EGFR is widely recognized for its importance i...  \n",
       "...                                                 ...  \n",
       "3914                                                NaN  \n",
       "3915                                                NaN  \n",
       "3916                                                NaN  \n",
       "3917  c-KIT activation has been shown to have oncoge...  \n",
       "3918                                                NaN  \n",
       "\n",
       "[3919 rows x 41 columns]"
      ]
     },
     "execution_count": 36,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#Removendo colunas repitidas\n",
    "Civic = Civic.drop(['gene_civic_url', 'Unnamed: 32', 'Unnamed: 31', 'Unnamed: 29',\n",
    "                    'Unnamed: 30', 'assertion_civic_urls', 'variant_civic_url', \n",
    "                    'evidence_civic_url', 'last_review_date', 'asco_abstract_id',\n",
    "                    'nct_ids', 'chromosome2', 'start2', 'stop2', 'representative_transcript2',\n",
    "                    'variant_groups'\n",
    "],axis=1)\n",
    "Civic"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "id": "d9a0af8f",
   "metadata": {
    "collapsed": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "gene                               0\n",
       "entrez_id                          0\n",
       "variant                            0\n",
       "disease                           23\n",
       "doid                              33\n",
       "phenotypes                      3408\n",
       "drugs                           1457\n",
       "evidence_type                      0\n",
       "evidence_direction               179\n",
       "clinical_significance            222\n",
       "variant_id                         0\n",
       "gene_id                            0\n",
       "is_flagged                         0\n",
       "drug_interaction_type           3300\n",
       "evidence_level                    22\n",
       "evidence_statement                22\n",
       "citation_id                       22\n",
       "source_type                       22\n",
       "citation                          22\n",
       "rating                            90\n",
       "evidence_status                   22\n",
       "evidence_id                       22\n",
       "chromosome                       457\n",
       "start                            458\n",
       "stop                             458\n",
       "reference_bases                 2022\n",
       "variant_bases                   2077\n",
       "representative_transcript        488\n",
       "ensembl_version                  497\n",
       "reference_build                  448\n",
       "variant_summary                 2532\n",
       "variant_origin                   370\n",
       "summary                         2518\n",
       "variant_types                    632\n",
       "hgvs_expressions                1962\n",
       "civic_variant_evidence_score       0\n",
       "allele_registry_id              1962\n",
       "clinvar_ids                     1839\n",
       "variant_aliases                 1505\n",
       "assertion_ids                   3445\n",
       "description                      762\n",
       "dtype: int64"
      ]
     },
     "execution_count": 37,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "Civic.isnull().sum()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 38,
   "id": "8256eb1b",
   "metadata": {},
   "outputs": [],
   "source": [
    "Civic.to_csv('Civic.csv', index=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 39,
   "id": "642439ff",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>gene</th>\n",
       "      <th>entrez_id</th>\n",
       "      <th>variant</th>\n",
       "      <th>disease</th>\n",
       "      <th>doid</th>\n",
       "      <th>phenotypes</th>\n",
       "      <th>drugs</th>\n",
       "      <th>evidence_type</th>\n",
       "      <th>evidence_direction</th>\n",
       "      <th>clinical_significance</th>\n",
       "      <th>...</th>\n",
       "      <th>variant_origin</th>\n",
       "      <th>summary</th>\n",
       "      <th>variant_types</th>\n",
       "      <th>hgvs_expressions</th>\n",
       "      <th>civic_variant_evidence_score</th>\n",
       "      <th>allele_registry_id</th>\n",
       "      <th>clinvar_ids</th>\n",
       "      <th>variant_aliases</th>\n",
       "      <th>assertion_ids</th>\n",
       "      <th>description</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>ERBB2</td>\n",
       "      <td>2064</td>\n",
       "      <td>Amplification</td>\n",
       "      <td>Her2-receptor Positive Breast Cancer</td>\n",
       "      <td>60079.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Trastuzumab</td>\n",
       "      <td>Predictive</td>\n",
       "      <td>Supports</td>\n",
       "      <td>Sensitivity/Response</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>CCND1 amplification has been implicated in poo...</td>\n",
       "      <td>transcript_amplification</td>\n",
       "      <td>NaN</td>\n",
       "      <td>47.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1,2</td>\n",
       "      <td>ERBB2, commonly referred to as HER2, is amplif...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>ALK</td>\n",
       "      <td>238</td>\n",
       "      <td>Fusion</td>\n",
       "      <td>Lung Non-small Cell Carcinoma</td>\n",
       "      <td>3908.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Crizotinib</td>\n",
       "      <td>Predictive</td>\n",
       "      <td>Supports</td>\n",
       "      <td>Sensitivity/Response</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Following the initial discovery and characteri...</td>\n",
       "      <td>transcript_fusion</td>\n",
       "      <td>NaN</td>\n",
       "      <td>648.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>REARRANGEMENT</td>\n",
       "      <td>3,34</td>\n",
       "      <td>ALK amplifications, fusions and mutations have...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>VHL</td>\n",
       "      <td>7428</td>\n",
       "      <td>R167Q (c.500G&gt;A)</td>\n",
       "      <td>Von Hippel-Lindau Disease</td>\n",
       "      <td>14175.0</td>\n",
       "      <td>Retinal capillary hemangioma,Pheochromocytoma,...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Predisposing</td>\n",
       "      <td>Supports</td>\n",
       "      <td>Pathogenic</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>R167Q is the most common point mutation in her...</td>\n",
       "      <td>missense_variant</td>\n",
       "      <td>NM_000551.3:c.500G&gt;A,NP_000542.1:p.Arg167Gln,N...</td>\n",
       "      <td>95.0</td>\n",
       "      <td>CA020454</td>\n",
       "      <td>2216</td>\n",
       "      <td>C.500G&gt;A,ARG167GLN,RS5030821</td>\n",
       "      <td>4</td>\n",
       "      <td>Von Hippel-Lindau (VHL) disease is characteriz...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>EGFR</td>\n",
       "      <td>1956</td>\n",
       "      <td>L858R</td>\n",
       "      <td>Lung Non-small Cell Carcinoma</td>\n",
       "      <td>3908.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Gefitinib,Erlotinib</td>\n",
       "      <td>Predictive</td>\n",
       "      <td>Supports</td>\n",
       "      <td>Sensitivity/Response</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>EGFR L858R has long been recognized as a funct...</td>\n",
       "      <td>missense_variant</td>\n",
       "      <td>NC_000007.13:g.55259515T&gt;G,NM_005228.4:c.2573T...</td>\n",
       "      <td>375.0</td>\n",
       "      <td>CA126713</td>\n",
       "      <td>376280,376282,16609</td>\n",
       "      <td>LEU858ARG,RS121434568</td>\n",
       "      <td>5,6</td>\n",
       "      <td>EGFR is widely recognized for its importance i...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>EGFR</td>\n",
       "      <td>1956</td>\n",
       "      <td>L858R</td>\n",
       "      <td>Lung Non-small Cell Carcinoma</td>\n",
       "      <td>3908.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Afatinib</td>\n",
       "      <td>Predictive</td>\n",
       "      <td>Supports</td>\n",
       "      <td>Sensitivity/Response</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>EGFR L858R has long been recognized as a funct...</td>\n",
       "      <td>missense_variant</td>\n",
       "      <td>NC_000007.13:g.55259515T&gt;G,NM_005228.4:c.2573T...</td>\n",
       "      <td>375.0</td>\n",
       "      <td>CA126713</td>\n",
       "      <td>376280,376282,16609</td>\n",
       "      <td>LEU858ARG,RS121434568</td>\n",
       "      <td>5,6</td>\n",
       "      <td>EGFR is widely recognized for its importance i...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3914</th>\n",
       "      <td>ERCC1</td>\n",
       "      <td>2067</td>\n",
       "      <td>Underexpression</td>\n",
       "      <td>Ovary Epithelial Cancer</td>\n",
       "      <td>2152.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Platinum Compound</td>\n",
       "      <td>Predictive</td>\n",
       "      <td>Supports</td>\n",
       "      <td>Sensitivity/Response</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>15.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3915</th>\n",
       "      <td>NTRK1</td>\n",
       "      <td>4914</td>\n",
       "      <td>Amplification</td>\n",
       "      <td>Solid Tumor</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Larotrectinib</td>\n",
       "      <td>Predictive</td>\n",
       "      <td>Supports</td>\n",
       "      <td>Sensitivity/Response</td>\n",
       "      <td>...</td>\n",
       "      <td>Somatic</td>\n",
       "      <td>NaN</td>\n",
       "      <td>transcript_amplification</td>\n",
       "      <td>NaN</td>\n",
       "      <td>5.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3916</th>\n",
       "      <td>CTCF</td>\n",
       "      <td>10664</td>\n",
       "      <td>K365T</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Functional</td>\n",
       "      <td>Supports</td>\n",
       "      <td>Gain of Function</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3917</th>\n",
       "      <td>KIT</td>\n",
       "      <td>3815</td>\n",
       "      <td>EXPRESSION</td>\n",
       "      <td>Glioblastoma</td>\n",
       "      <td>3068.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Sunitinib</td>\n",
       "      <td>Predictive</td>\n",
       "      <td>Supports</td>\n",
       "      <td>Sensitivity/Response</td>\n",
       "      <td>...</td>\n",
       "      <td>Somatic</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>20.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>c-KIT activation has been shown to have oncoge...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3918</th>\n",
       "      <td>SSTR5</td>\n",
       "      <td>6755</td>\n",
       "      <td>expression</td>\n",
       "      <td>Neuroendocrine Tumor</td>\n",
       "      <td>169.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Pasireotide</td>\n",
       "      <td>Predictive</td>\n",
       "      <td>Supports</td>\n",
       "      <td>Sensitivity/Response</td>\n",
       "      <td>...</td>\n",
       "      <td>Somatic</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>3919 rows × 41 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "       gene  entrez_id           variant  \\\n",
       "0     ERBB2       2064     Amplification   \n",
       "1       ALK        238            Fusion   \n",
       "2       VHL       7428  R167Q (c.500G>A)   \n",
       "3      EGFR       1956             L858R   \n",
       "4      EGFR       1956             L858R   \n",
       "...     ...        ...               ...   \n",
       "3914  ERCC1       2067   Underexpression   \n",
       "3915  NTRK1       4914     Amplification   \n",
       "3916   CTCF      10664             K365T   \n",
       "3917    KIT       3815        EXPRESSION   \n",
       "3918  SSTR5       6755        expression   \n",
       "\n",
       "                                   disease     doid  \\\n",
       "0     Her2-receptor Positive Breast Cancer  60079.0   \n",
       "1            Lung Non-small Cell Carcinoma   3908.0   \n",
       "2                Von Hippel-Lindau Disease  14175.0   \n",
       "3            Lung Non-small Cell Carcinoma   3908.0   \n",
       "4            Lung Non-small Cell Carcinoma   3908.0   \n",
       "...                                    ...      ...   \n",
       "3914               Ovary Epithelial Cancer   2152.0   \n",
       "3915                           Solid Tumor      NaN   \n",
       "3916                                   NaN      NaN   \n",
       "3917                          Glioblastoma   3068.0   \n",
       "3918                  Neuroendocrine Tumor    169.0   \n",
       "\n",
       "                                             phenotypes                drugs  \\\n",
       "0                                                   NaN          Trastuzumab   \n",
       "1                                                   NaN           Crizotinib   \n",
       "2     Retinal capillary hemangioma,Pheochromocytoma,...                  NaN   \n",
       "3                                                   NaN  Gefitinib,Erlotinib   \n",
       "4                                                   NaN             Afatinib   \n",
       "...                                                 ...                  ...   \n",
       "3914                                                NaN    Platinum Compound   \n",
       "3915                                                NaN        Larotrectinib   \n",
       "3916                                                NaN                  NaN   \n",
       "3917                                                NaN            Sunitinib   \n",
       "3918                                                NaN          Pasireotide   \n",
       "\n",
       "     evidence_type evidence_direction clinical_significance  ...  \\\n",
       "0       Predictive           Supports  Sensitivity/Response  ...   \n",
       "1       Predictive           Supports  Sensitivity/Response  ...   \n",
       "2     Predisposing           Supports            Pathogenic  ...   \n",
       "3       Predictive           Supports  Sensitivity/Response  ...   \n",
       "4       Predictive           Supports  Sensitivity/Response  ...   \n",
       "...            ...                ...                   ...  ...   \n",
       "3914    Predictive           Supports  Sensitivity/Response  ...   \n",
       "3915    Predictive           Supports  Sensitivity/Response  ...   \n",
       "3916    Functional           Supports      Gain of Function  ...   \n",
       "3917    Predictive           Supports  Sensitivity/Response  ...   \n",
       "3918    Predictive           Supports  Sensitivity/Response  ...   \n",
       "\n",
       "      variant_origin                                            summary  \\\n",
       "0                NaN  CCND1 amplification has been implicated in poo...   \n",
       "1                NaN  Following the initial discovery and characteri...   \n",
       "2                NaN  R167Q is the most common point mutation in her...   \n",
       "3                NaN  EGFR L858R has long been recognized as a funct...   \n",
       "4                NaN  EGFR L858R has long been recognized as a funct...   \n",
       "...              ...                                                ...   \n",
       "3914             NaN                                                NaN   \n",
       "3915         Somatic                                                NaN   \n",
       "3916             NaN                                                NaN   \n",
       "3917         Somatic                                                NaN   \n",
       "3918         Somatic                                                NaN   \n",
       "\n",
       "                 variant_types  \\\n",
       "0     transcript_amplification   \n",
       "1            transcript_fusion   \n",
       "2             missense_variant   \n",
       "3             missense_variant   \n",
       "4             missense_variant   \n",
       "...                        ...   \n",
       "3914                       NaN   \n",
       "3915  transcript_amplification   \n",
       "3916                       NaN   \n",
       "3917                       NaN   \n",
       "3918                       NaN   \n",
       "\n",
       "                                       hgvs_expressions  \\\n",
       "0                                                   NaN   \n",
       "1                                                   NaN   \n",
       "2     NM_000551.3:c.500G>A,NP_000542.1:p.Arg167Gln,N...   \n",
       "3     NC_000007.13:g.55259515T>G,NM_005228.4:c.2573T...   \n",
       "4     NC_000007.13:g.55259515T>G,NM_005228.4:c.2573T...   \n",
       "...                                                 ...   \n",
       "3914                                                NaN   \n",
       "3915                                                NaN   \n",
       "3916                                                NaN   \n",
       "3917                                                NaN   \n",
       "3918                                                NaN   \n",
       "\n",
       "     civic_variant_evidence_score allele_registry_id          clinvar_ids  \\\n",
       "0                            47.0                NaN                  NaN   \n",
       "1                           648.0                NaN                  NaN   \n",
       "2                            95.0           CA020454                 2216   \n",
       "3                           375.0           CA126713  376280,376282,16609   \n",
       "4                           375.0           CA126713  376280,376282,16609   \n",
       "...                           ...                ...                  ...   \n",
       "3914                         15.0                NaN                  NaN   \n",
       "3915                          5.0                NaN                  NaN   \n",
       "3916                          0.0                NaN                  NaN   \n",
       "3917                         20.0                NaN                  NaN   \n",
       "3918                          0.0                NaN                  NaN   \n",
       "\n",
       "                   variant_aliases assertion_ids  \\\n",
       "0                              NaN           1,2   \n",
       "1                    REARRANGEMENT          3,34   \n",
       "2     C.500G>A,ARG167GLN,RS5030821             4   \n",
       "3            LEU858ARG,RS121434568           5,6   \n",
       "4            LEU858ARG,RS121434568           5,6   \n",
       "...                            ...           ...   \n",
       "3914                           NaN           NaN   \n",
       "3915                           NaN           NaN   \n",
       "3916                           NaN           NaN   \n",
       "3917                           NaN           NaN   \n",
       "3918                           NaN           NaN   \n",
       "\n",
       "                                            description  \n",
       "0     ERBB2, commonly referred to as HER2, is amplif...  \n",
       "1     ALK amplifications, fusions and mutations have...  \n",
       "2     Von Hippel-Lindau (VHL) disease is characteriz...  \n",
       "3     EGFR is widely recognized for its importance i...  \n",
       "4     EGFR is widely recognized for its importance i...  \n",
       "...                                                 ...  \n",
       "3914                                                NaN  \n",
       "3915                                                NaN  \n",
       "3916                                                NaN  \n",
       "3917  c-KIT activation has been shown to have oncoge...  \n",
       "3918                                                NaN  \n",
       "\n",
       "[3919 rows x 41 columns]"
      ]
     },
     "execution_count": 39,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df = pd.read_csv('Civic.csv')\n",
    "df"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.9.7"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
